Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating cerebrovascular disease

A technology for cerebrovascular diseases and drugs, applied in the field of drugs for the treatment of cerebrovascular diseases, can solve problems such as high disability rate, low neurological deficit score, and low efficiency

Inactive Publication Date: 2006-04-26
王步高
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] With the increasing incidence of cerebrovascular disease, it is now recognized as one of the important diseases that endanger human health, and the disability rate is high and the cure rate is low, which has caused great harm to patients and brought great harm to society and families. However, some drugs currently disclosed for the treatment of cerebrovascular diseases have low efficacy rates, and the neurological deficit score is obviously not high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Weigh 3 grams of Chinese medicine raw material hive, 6 grams of Chuanxiong, 5 grams of ants, 12 grams of Astragalus, and 3 grams of leeches.

[0032] Mix ants and leeches in proportion, freeze-dry them at -15°C, process and crush them into fineness of 120 meshes; decoct Astragalus, Rhizoma Chuanxiong, and hives in proportion, concentrate them into extracts, dry them, and mix the above-mentioned medicines in proportion After mixing, ripen and sterilize at 100-110°C for 30 minutes, then pack into capsules, about 15 grams per dose, 0.45 grams per capsule, 5 capsules each time, 3 times / day, after meals.

Embodiment 2

[0034] Weigh 30 grams of Chinese medicine raw material hive, 30 grams of Rhizoma Chuanxiong, 60 grams of ants, 60 grams of Astragalus, and 20 grams of leeches.

[0035] Mix ants and leeches in proportion, freeze-dry them at -15°C, process and crush them into fineness of 120 meshes; decoct Astragalus, Rhizoma Chuanxiong, and hives in proportion, concentrate them into extracts, dry them, and mix the above-mentioned medicines in proportion After mixing, ripen and sterilize at 100-110°C for 30 minutes, then pack into capsules, about 15 grams per dose, 0.45 grams per capsule, 5 capsules each time, 3 times / day, after meals.

Embodiment 3

[0037] Weigh 12 grams of Chinese medicine raw material hive, 27 grams of Rhizoma Chuanxiong, 18 grams of ants, 48 ​​grams of Astragalus, and 12 grams of leeches.

[0038] Mix ants and leeches in proportion, freeze-dry them at -15°C, process and crush them into fineness of 120 meshes; decoct Astragalus, Rhizoma Chuanxiong, and hives in proportion, concentrate them into extracts, dry them, and mix the above-mentioned medicines in proportion After mixing, ripen and sterilize at 100-110°C for 30 minutes, then pack into capsules, about 15 grams per dose, 0.45 grams per capsule, 5 capsules each time, 3 times / day, after meals.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is one kind of Chinese medicine for treating cerebral vascular disease. The medicine is prepared with honeycomb, Chuanxiong rhizome, ant, astragalus root and leech in certain proportion. The preparation process includes decocting astragalus root, Chuanxiong rhizome and honeycomb and concentration to obtain extractum; freeze drying ant a leech at -15 deg.c and crushing to 120 mesh; mixing the extractum and the medicine powder, slaking at 100-110 deg.c, sterilizing for 30 min and capsulizing. Clinical application shows that the present invention has high curative effect on nerve function default.

Description

technical field [0001] The invention is a medicine for treating cerebrovascular diseases made from traditional Chinese medicines. Background technique [0002] With the increasing incidence of cerebrovascular disease, it is currently recognized as one of the important diseases that endanger human health, and the disability rate is high and the cure rate is low, which has caused great harm to patients and brought great harm to society and families. However, some drugs currently disclosed for the treatment of cerebrovascular diseases have low efficacy rates, and the neurological deficit score is obviously not high. Contents of the invention [0003] The invention solves the technical problem of high disability rate and low cure rate caused by cerebrovascular diseases, and provides a medicine for treating cerebrovascular diseases, which uses traditional Chinese medicine hive, ant, leech, astragalus and chuanxiong as active ingredients. [0004] The present invention is achie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/481A61K35/62A61K35/64A61K9/48A61P9/00A61P9/10
Inventor 王步高王琦
Owner 王步高
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products